402
Views
9
CrossRef citations to date
0
Altmetric
Nose/Sinus

Influenza A virus infection induces indoleamine 2,3-dioxygenase (IDO) expression and modulates subsequent inflammatory mediators in nasal epithelial cells

, & ORCID Icon
Pages 149-156 | Received 30 Sep 2019, Accepted 21 Nov 2019, Published online: 18 Dec 2019

References

  • Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA. 2009;106(9):3455–3460.
  • Medina RA, Garcia-Sastre A. Influenza A viruses: new research developments. Nat Rev Microbiol. 2011;9(8):590–603.
  • Swamy M, Jamora C, Havran W, et al. Epithelial decision makers: in search of the ‘epimmunome’. Nat Immunol. 2010;11(8):656–665.
  • Thai M, Thaker SK, Feng J, et al. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat Commun. 2015;6(1):8873.
  • Yeh TH, Tsai CH, Chen YS, et al. Increased communication among nasal epithelial cells in air-liquid interface culture. Laryngoscope. 2007;117(8):1439–1444.
  • Lin SJ, Lo M, Kuo RL, et al. The pathological effects of CCR2+ inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection. J Biomed Sci. 2014;21(1):99.
  • Assmann N, Finlay DK. Metabolic regulation of immune responses: therapeutic opportunities. J Clin Invest. 2016;126(6):2031–2039.
  • van Wissen M, Snoek M, Smids B, et al. IFN-gamma amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. J Immunol. 2002;169(12):7039–7044.
  • Paveglio SA, Allard J, Foster Hodgkins SR, et al. Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure. Am J Respir Cell Mol Biol. 2011;44(1):11–23.
  • Bhutia YD, Babu E, Ganapathy V. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells. Biochim Biophys Acta. 2015;1848(2):453–462.
  • Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest. 2004;114(2):270–279.
  • Luukkainen A, Toppila-Salmi S. Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence. Curr Opin Allergy Clin Immunol. 2013;13(1):37–44.
  • Fox JM, Sage LK, Poore S, et al. Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection. J Leukoc Biol. 2014;96(3):447–452.
  • Fox JM, Crabtree JM, Sage LK, et al. Interferon lambda upregulates IDO1 expression in respiratory epithelial cells after influenza virus infection. J Interferon Cytokine Res. 2015;35(7):554–562.
  • Chandler JD, Hu X, Ko EJ, et al. Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice. Am J Physiol Regul Integr Comp Physiol. 2016;311(5):R906–R916.
  • Gostner JM, Becker K, Überall F, et al. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment. Expert Opin Ther Targets. 2015;19(5):605–615.
  • Jiang N, Zhao G, Lin J, et al. Indoleamine 2,3-dioxygenase is involved in the inflammation response of corneal epithelial cells to Aspergillus fumigatus infections. PLoS One. 2015;10(9):e0137423.
  • Loughman JA, Hunstad DA. Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis. 2012;205(12):1830–1839.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.